TORRENT FDA Approval ANDA 211975

ANDA 211975

TORRENT

FDA Drug Application

Application #211975

Application Sponsors

ANDA 211975TORRENT

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET, DELAYED RELEASE;ORAL250MG0ERYTHROMYCINERYTHROMYCIN
002TABLET, DELAYED RELEASE;ORAL500MG0ERYTHROMYCINERYTHROMYCIN

FDA Submissions

UNKNOWN; ORIG1AP2021-07-26STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

TORRENT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211975
            [companyName] => TORRENT
            [docInserts] => ["",""]
            [products] => [{"drugName":"ERYTHROMYCIN","activeIngredients":"ERYTHROMYCIN","strength":"250MG","dosageForm":"TABLET, DELAYED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ERYTHROMYCIN","activeIngredients":"ERYTHROMYCIN","strength":"500MG","dosageForm":"TABLET, DELAYED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/26\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-07-26
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.